CN1292796A - Meth1和meth2多核苷酸及多肽 - Google Patents

Meth1和meth2多核苷酸及多肽 Download PDF

Info

Publication number
CN1292796A
CN1292796A CN998034959A CN99803495A CN1292796A CN 1292796 A CN1292796 A CN 1292796A CN 998034959 A CN998034959 A CN 998034959A CN 99803495 A CN99803495 A CN 99803495A CN 1292796 A CN1292796 A CN 1292796A
Authority
CN
China
Prior art keywords
seq
amino acids
polypeptide
coding
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN998034959A
Other languages
English (en)
Chinese (zh)
Inventor
L·伊卢拉－阿里斯普
G·A·哈斯丁斯
S·M·鲁本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center
Original Assignee
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Beth Israel Deaconess Medical Center filed Critical Human Genome Sciences Inc
Publication of CN1292796A publication Critical patent/CN1292796A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN998034959A 1998-01-23 1999-01-22 Meth1和meth2多核苷酸及多肽 Pending CN1292796A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7229898P 1998-01-23 1998-01-23
US9853998P 1998-08-28 1998-08-28
US60/072,298 1998-08-28
US60/098,539 1998-08-28

Publications (1)

Publication Number Publication Date
CN1292796A true CN1292796A (zh) 2001-04-25

Family

ID=26753215

Family Applications (1)

Application Number Title Priority Date Filing Date
CN998034959A Pending CN1292796A (zh) 1998-01-23 1999-01-22 Meth1和meth2多核苷酸及多肽

Country Status (9)

Country Link
EP (1) EP1049708A4 (enExample)
JP (1) JP2002501077A (enExample)
KR (1) KR20010086224A (enExample)
CN (1) CN1292796A (enExample)
AU (1) AU766787B2 (enExample)
CA (1) CA2319109A1 (enExample)
MX (1) MXPA00007165A (enExample)
NZ (1) NZ505855A (enExample)
WO (1) WO1999037660A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416974B1 (en) 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids
DE19806581A1 (de) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Sequenzen eines Ih-Ionenkanals und deren Verwendung
US6649377B1 (en) * 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
ATE444971T1 (de) * 1999-06-09 2009-10-15 Genentech Inc Zusammensetzungen und verfahren für die tumor- behandlung
US6395889B1 (en) * 1999-09-09 2002-05-28 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding human protease homologs
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
WO2001074852A2 (en) * 2000-03-31 2001-10-11 Bayer Corporation Protein having activity as an angiogenesis modulator
JP2002330761A (ja) * 2000-04-26 2002-11-19 Pfizer Prod Inc Ａｄａｍｔｓポリペプチド、それをコードする核酸、及びその使用
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
IL158293A0 (en) 2001-04-10 2004-05-12 Agensys Inc Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
AU2002364161A1 (en) 2001-12-12 2003-06-23 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
ATE441713T1 (de) 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
JP5606322B2 (ja) 2008-10-20 2014-10-15 昇志 佐藤 腫瘍抗原ペプチド及びその利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565858B2 (en) * 1997-06-03 2003-05-20 Kureha Chemical Industry Co., Ltd. Human ADAMTS-1 protein and pharmaceutical composition
US6416974B1 (en) * 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids

Also Published As

Publication number Publication date
KR20010086224A (ko) 2001-09-10
CA2319109A1 (en) 1999-07-29
EP1049708A4 (en) 2002-09-04
AU2464199A (en) 1999-08-09
WO1999037660A1 (en) 1999-07-29
WO1999037660A9 (en) 1999-10-14
AU766787B2 (en) 2003-10-23
MXPA00007165A (es) 2002-06-21
JP2002501077A (ja) 2002-01-15
NZ505855A (en) 2005-01-28
EP1049708A1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
CN1214050A (zh) 人肿瘤坏死因子δ和ε
CN1552855A (zh) 人血管内皮生长因子2
CA2319109A1 (en) Meth1 and meth2 polynucleotides and polypeptides
WO2003020005A2 (en) Lp mammalian proteins; related reagents
JP2003500041A (ja) Ｍｅｔｈ１およびｍｅｔｈ２ポリヌクレオチドおよびポリペプチド
CA2298852A1 (en) 83 human secreted proteins
EP1053308A1 (en) Dendritic enriched secreted lymphocyte activation molecule
CN1304410C (zh) 肿瘤坏死因子－γ
CN1166776C (zh) 人血管ibp样生长因子在制备用于诊断血管疾病或与肿瘤形成相关的新血管化的诊断剂中的应用
CN1703422A (zh) Meth1和meth2多核苷酸及多肽
CN1148381C (zh) 新的人趋化因子巨噬细胞炎性蛋白、其编码序列及用途
CN1185159A (zh) 人血管内皮生长因子3
AU2004200046A1 (en) Meth1 and Meth2 Polynucleotides and Polypeptides
CN1183803A (zh) 成纤维细胞生长因子－14
CN1185175A (zh) 成纤维细胞生长因子13
CN1270222A (zh) 一种新的人辅酶ⅰ亚基异构体蛋白及其编码序列
CN1414021A (zh) 成纤维细胞生长因子13的抗体、拮抗剂及激动剂
CN1373216A (zh) 肌细胞增殖抑制因子Fwa267
CN1271009A (zh) 一种新的人二酰甘油焦磷酸盐磷酸酶蛋白及其编码序列
CN1183804A (zh) 成纤维细胞生长因子15
CN1182432A (zh) 人神经肽受体
CN1301869A (zh) 新的人促分裂原活化蛋白激酶磷酸酶及其编码序列
CN1270220A (zh) 一种新的人维生素b12相关蛋白及其编码序列
HK1037679A (en) Vascular endothelial growth factor 2
CN1272542A (zh) 一种人蛋白磷酸聚糖蛋白及其编码序列

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication